alzheimersdisease
Scientists studying a family with early Alzheimer’s have found that some carry a genetic mutation that delays their initial symptoms. The hope is that this could help researchers find new ways of stopping the neurodegenerative disease if they can figure out how one copy of the very rare gene variant offers some protection. “It opens new avenues,” said Yakeel Quiroz, a neuropsychologist at Massachusetts General Hospital in the US, who helped lead the study published on Wednesday. “There are definitely opportunities to copy or mimic the effects.” Genetic protectionResearchers studying a family i...
Euronews (English)
Imagine a future where the smell of menthol could alleviate some of the worst symptoms of Alzheimer’s disease. This might sound like science fiction, but innovative new research is making it a potential reality. Scientists have discovered that when mice with Alzheimer’s inhaled menthol, their cognitive abilities improved. This unexpected finding highlights a potential new avenue for treating this debilitating condition. Alzheimer’s disease is a serious neurodegenerative disorder that gets worse over time. It is characterised by changes in the brain that result in loss of neurons and connection...
PsyPost
Imagine a future where the smell of menthol could alleviate some of the worst symptoms of Alzheimer’s disease. This might sound like science fiction, but innovative new research is making it a potential reality. Scientists have discovered that when mice with Alzheimer’s inhaled menthol, their cognitive abilities improved. This unexpected finding highlights a potential new avenue for treating this debilitating condition. Alzheimer’s disease is a serious neurodegenerative disorder that gets worse over time. It is characterised by changes in the brain that result in loss of neurons and connection...
PsyPost (UK)
Imagine a future where the smell of menthol could alleviate some of the worst symptoms of Alzheimer’s disease. This might sound like science fiction, but innovative new research is making it a potential reality. Scientists have discovered that when mice with Alzheimer’s inhaled menthol, their cognitive abilities improved. This unexpected finding highlights a potential new avenue for treating this debilitating condition. Alzheimer’s disease is a serious neurodegenerative disorder that gets worse over time. It is characterised by changes in the brain that result in loss of neurons and connection...
PsyPost (CA)
New research provides evidence that using two common Alzheimer’s disease medications together can significantly increase patients’ chances of surviving beyond five years from diagnosis. The study, published in Communications Medicine, suggests that this combined treatment could extend the lives of approximately 303,000 people with Alzheimer’s disease in the United States. Alzheimer’s disease is the most common form of dementia, characterized by progressive memory loss, cognitive decline, and behavioral changes. It affects over 50 million people worldwide and is a leading cause of death. Alzhei...
PsyPost (CA)
New research provides evidence that using two common Alzheimer’s disease medications together can significantly increase patients’ chances of surviving beyond five years from diagnosis. The study, published in Communications Medicine, suggests that this combined treatment could extend the lives of approximately 303,000 people with Alzheimer’s disease in the United States. Alzheimer’s disease is the most common form of dementia, characterized by progressive memory loss, cognitive decline, and behavioral changes. It affects over 50 million people worldwide and is a leading cause of death. Alzhei...
PsyPost (UK)
New research provides evidence that using two common Alzheimer’s disease medications together can significantly increase patients’ chances of surviving beyond five years from diagnosis. The study, published in Communications Medicine, suggests that this combined treatment could extend the lives of approximately 303,000 people with Alzheimer’s disease in the United States. Alzheimer’s disease is the most common form of dementia, characterized by progressive memory loss, cognitive decline, and behavioral changes. It affects over 50 million people worldwide and is a leading cause of death. Alzhei...
PsyPost
A panel of advisers to US health regulators backed a drug to slow Alzheimer's disease on Monday setting the stage for its expected approval for patients at an early stage of the disease. The advisers voted unanimously that the drug's benefits outweighed its risks, which include side effects like brain swelling and bleeding that will have to be monitored. "I thought the evidence was very strong in the trial showing the effectiveness of the drug," said panel member Dean Follmann, a National Institutes of Health statistician. The drug, donanemab, is from pharmaceutical company Eli Lilly and has b...
Euronews (English)
A groundbreaking study published in Acta Neuropathologica has identified a genetic variant that can reduce the risk of developing Alzheimer’s disease by up to 70%. This variant appears to help in removing toxic amyloid from the brain through the blood-brain barrier, highlighting the significant role that blood vessels in the brain may play in Alzheimer’s disease. These findings could pave the way for new therapeutic approaches to prevent or treat Alzheimer’s disease. “Alzheimer’s disease may get started with amyloid deposits in the brain, but the disease manifestations are the result of change...
PsyPost
A groundbreaking study published in Acta Neuropathologica has identified a genetic variant that can reduce the risk of developing Alzheimer’s disease by up to 70%. This variant appears to help in removing toxic amyloid from the brain through the blood-brain barrier, highlighting the significant role that blood vessels in the brain may play in Alzheimer’s disease. These findings could pave the way for new therapeutic approaches to prevent or treat Alzheimer’s disease. “Alzheimer’s disease may get started with amyloid deposits in the brain, but the disease manifestations are the result of change...
PsyPost (CA)
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら